| Not Yet Recruiting | Viromes in Infants Presenting With a Septic Syndrome NCT07470541 | University Hospital, Montpellier | N/A |
| Recruiting | School Inner City Air Study NCT05953233 | Massachusetts General Hospital | N/A |
| Recruiting | A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis NCT06931002 | Imperial College London | N/A |
| Recruiting | Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848) NCT06488118 | Akhilesh Jha | N/A |
| Recruiting | Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO NCT06025682 | Gruppo Italiano Malattie EMatologiche dell'Adulto | — |
| Active Not Recruiting | Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Eme NCT06271655 | Christopher Payette | N/A |
| Completed | RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection NCT06149494 | Altesa Biosciences, Inc. | Phase 2 |
| Not Yet Recruiting | Isotonic Saline for Children With Bronchiolitis NCT05902702 | Slagelse Hospital | N/A |
| Completed | Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO NCT05897801 | Hellenic Institute for the Study of Sepsis | — |
| Recruiting | COMPArative Study of the Consequence on innaTe Immune Response du to Bacterial or Viral Infection in Patients NCT05671159 | University Hospital, Limoges | N/A |
| Completed | Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology. NCT05717283 | University Hospital, Caen | N/A |
| Unknown | InfluenCEF Study: Study on the Headache Associated With Influenza Infection NCT05704335 | Hospital Clínico Universitario de Valladolid | — |
| Unknown | An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity NCT05568953 | Singapore General Hospital | Phase 2 |
| Recruiting | REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or A NCT05246098 | McMaster University | — |
| Completed | Pharmacokinetics and Bioequivalence of Molnupiravir, 200 mg Capsules and Lagevrio, 200 mg Capsules in Healthy NCT05412173 | Valenta Pharm JSC | N/A |
| Completed | Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway NCT05467007 | Andrew Meltzer | N/A |
| Recruiting | Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts NCT04691622 | Children's National Research Institute | Phase 1 |
| Completed | Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection NCT05226949 | Rigshospitalet, Denmark | — |
| Completed | Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection NCT04267809 | Singapore General Hospital | Phase 2 |
| Recruiting | Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract NCT05603650 | University of California, Irvine | N/A |
| Recruiting | TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. NCT04013802 | Baylor College of Medicine | Phase 1 |
| Recruiting | Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infection NCT04230356 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Completed | Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip NCT04980534 | Catalysis SL | N/A |
| Withdrawn | Viral Specific T-cells for Treatment of COVID-19 NCT04406064 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Completed | The Role of Lactate in Viral and Bacterial Infection NCT04777747 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | — |
| Completed | Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2 NCT04655521 | Universität des Saarlandes | — |
| Terminated | Anti-SARS Cov-2 T Cell Infusions for COVID 19 NCT04401410 | Baylor College of Medicine | Phase 1 |
| Completed | Anakinra in the Management of COVID-19 Infection NCT04643678 | Hamad Medical Corporation | Phase 2 / Phase 3 |
| Completed | Immune Responses With Reduxium NCT04525456 | Ogevity Therapeutics, Inc. | N/A |
| Unknown | Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic NCT04583449 | University of East London | N/A |
| Active Not Recruiting | Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant NCT04331275 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Completed | Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Co NCT04533906 | Marinomed Biotech AG | N/A |
| Completed | Metformin in Dengue With Obesity NCT04377451 | Oxford University Clinical Research Unit, Vietnam | Phase 1 / Phase 2 |
| Unknown | Obesity Surgery During 2020 Italian Pandemic NCT04480034 | University of Roma La Sapienza | — |
| Recruiting | Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) NCT04197596 | New York Medical College | Phase 1 / Phase 2 |
| Unknown | Knowledge About Covid-19 Infection in Pregnant Women NCT04423692 | Aljazeera Hospital | — |
| Completed | Host RNA Profiles to Detect Infections in Young Infants NCT04823026 | Rigshospitalet, Denmark | — |
| Unknown | Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit NCT04355481 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections NCT04356144 | Medical University of Vienna | — |
| Completed | Implementation of Academic Detailing Interventions on Prescribing of Antimicrobial Drugs in Primary Health Car NCT05090475 | General Hospital Koprivnica | N/A |
| Completed | Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory NCT04705753 | University of Crete | Phase 2 / Phase 3 |
| Unknown | Evaluation of Newborns Presenting With Suspected COVID 19 NCT04519307 | Dr. Behcet Uz Children's Hospital | — |
| Completed | Smell Changes & Efficacy of Nasal Theophylline NCT03990766 | Washington University School of Medicine | Phase 2 |
| Completed | Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cel NCT03883906 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Unknown | Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections NCT03846921 | Hillel Yaffe Medical Center | — |
| Completed | Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia NCT03996967 | Boston University | — |
| Unknown | Proviral DNA as a Target for HIV-1 Resistance Analysis NCT04088916 | University of Chile | — |
| Recruiting | Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis NCT03594981 | Catherine Bollard | Phase 1 / Phase 2 |
| Unknown | The Search for Viral and Bacterial Etiology of Varicocele NCT03079609 | Medical University of Warsaw | N/A |
| Unknown | A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-resp NCT04254991 | MeMed Diagnostics Ltd. | — |
| Terminated | Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subje NCT02696291 | Emergent BioSolutions | Phase 1 |
| Completed | Electronic Medical Records to Increase Adherence to the Choosing Wisely Recommendations NCT05385445 | University of Manitoba | N/A |
| Recruiting | Third Party Viral Specific T-cells (VSTs) NCT02532452 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Completed | Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV) NCT02605109 | Konkuk University Medical Center | — |
| Unknown | Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in Ch NCT02456610 | Affiliated Hospital to Academy of Military Medical Sciences | Phase 1 |
| Completed | Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children NCT03191097 | Valenta Pharm JSC | Phase 3 |
| Completed | Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Heal NCT02061358 | Emergent BioSolutions | Phase 1 |
| Recruiting | Donor-Derived Viral Specific T-cells (VSTs) NCT02048332 | Children's Hospital Medical Center, Cincinnati | Phase 1 / Phase 2 |
| Completed | ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis NCT01883180 | Nanfang Hospital, Southern Medical University | Phase 4 |
| Completed | ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & NCT01570283 | AlloVir | Phase 1 / Phase 2 |
| Completed | Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients NCT03206346 | Valenta Pharm JSC | Phase 3 |
| Unknown | Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations NCT01520051 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 |
| Completed | Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection NCT01347736 | Mayo Clinic | N/A |
| Completed | Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections NCT03189537 | Valenta Pharm JSC | Phase 3 |
| Unknown | The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children NCT01159470 | Shaare Zedek Medical Center | — |
| Completed | Antimicrobial Stewardship for Primary Care Pediatricians NCT01806103 | Children's Hospital of Philadelphia | N/A |
| Terminated | Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunte NCT00952185 | City of Hope Medical Center | N/A |
| Completed | Validation of Self-Reported Needle Sharing Among Injection Drug Users NCT00341081 | National Cancer Institute (NCI) | — |